NOLAN BAULDREE: Open Payments
NPI 1427642594 · HELENA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,970 in 117 payments from 16 companies in 2025. Trend: 2023 $920 · 2024 $2,411 · 2025 $1,970
Food & beverage: $1,956Entertainment: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $478 |
| Novo Nordisk Inc | 25 | $371 |
| AstraZeneca Pharmaceuticals LP | 11 | $187 |
| PFIZER INC. | 7 | $165 |
| GlaxoSmithKline, LLC. | 9 | $146 |
| Amgen Inc. | 6 | $115 |
| Axsome Therapeutics, Inc. | 4 | $104 |
| Exact Sciences Corporation | 6 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| SHIELD THERAPEUTICS INC | 3 | $61 |
Products named: Ozempic, UBRELVY, AIRSUPRA, VRAYLAR, TRELEGY ELLIPTA, QULIPTA, Wegovy, Auvelity.
Industry payments across AL — which companies pay providers there.
